Envestnet Portfolio Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50M Buy
41,689
+2,976
+8% +$3.04M 0.24% 69
2026
Q1
$35.6M Sell
38,713
-17,321
-31% -$17.6M 0.2% 77
2025
Q4
$60.2M Buy
56,034
+9,906
+21% +$9.47M 0.21% 67
2025
Q3
$35.2M Buy
46,128
+7,869
+21% +$5.86M 0.13% 88
2025
Q2
$29.8M Sell
38,259
-6,034
-14% -$4.69M 0.11% 101
2025
Q1
$36.6M Sell
44,293
-3,018
-6% -$2.51M 0.14% 85
2024
Q4
$36.5M Buy
47,311
+5,184
+12% +$4.29M 0.12% 92
2024
Q3
$37.3M Buy
42,127
+6,075
+17% +$5.46M 0.12% 89
2024
Q2
$32.6M Buy
36,052
+2,481
+7% +$1.98M 0.11% 98
2024
Q1
$26.1M Buy
33,571
+6,912
+26% +$4.92M 0.1% 108
2023
Q4
$15.5M Sell
26,659
-983
-4% -$574K 0.06% 148
2023
Q3
$14.8M Buy
+27,642
New +$14.2M 0.07% 141

Other funds holding LLY

Envestnet Portfolio Solutions's LLY Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Eli Lilly (LLY) stake by 7.7% in Q2 2026, buying an estimated $3.04M and bringing the position to 41,689 shares worth $50M. The position accounts for 0.24% of the portfolio, ranked #69.

Envestnet Portfolio Solutions first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $60.2M in Q4 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Envestnet Portfolio Solutions held 41,689 shares of Eli Lilly worth $50M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 2,976 Eli Lilly shares in Q2 2026, an estimated $3.04M.
  • Eli Lilly made up 0.24% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #69 holding.
  • Envestnet Portfolio Solutions first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Eli Lilly position peaked at $60.2M in Q4 2025.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.